Responsibilities:Leading implementation of corporate re-structure to support Tigermed globalization with international and domestic mergers/acquisitions and business conduct excellency to maximize R&R, in the areas of medicine, medical device, vaccine and across registration-purpose, post-market research. Leading planning and launching business unit of real world study, managing CEO office and acting as Chief Medical Officer, Hangzhou Vongi Health Tech. Ltd., and was responsible for… Show more Responsibilities:Leading implementation of corporate re-structure to support Tigermed globalization with international and domestic mergers/acquisitions and business conduct excellency to maximize R&R, in the areas of medicine, medical device, vaccine and across registration-purpose, post-market research. Leading planning and launching business unit of real world study, managing CEO office and acting as Chief Medical Officer, Hangzhou Vongi Health Tech. Ltd., and was responsible for overall operations of Tigermed subsidiary, SIMO/Site Management Organization:• Planning and implementing strategy for business sustainable growth and conduct excellency;• Establishing CEO office and overseeing daily operations, liaison between CEO and 70+ subsidiaries and investments, managing 15 core initiatives, for example: innovation, digitalization, therapeutic initiative and talent recruitment/development program;• Overseeing external affairs, and corporate social responsibility (CSR);• Establishing and managing procurement system.Achievements:• Exceeded SIMO annual target by 27% with 57% growth and paved the way for 84% growth in the following year; • Registered first digital medical device in China. Show less

Responsibilities:• Established overall policy advocacy strategy with in-depth analyzes and mapping exercises; • Established partnerships with the central and local government agencies, academic institutes and think-tanks/KoLs; • Earned trust and gained endorsement from public policy makers from China and US;• Built and managed team with 15 headcounts.Achievements:• Established strategic partnership of National Health Commission (NHC) as essential partner for infectious… Show more Responsibilities:• Established overall policy advocacy strategy with in-depth analyzes and mapping exercises; • Established partnerships with the central and local government agencies, academic institutes and think-tanks/KoLs; • Earned trust and gained endorsement from public policy makers from China and US;• Built and managed team with 15 headcounts.Achievements:• Established strategic partnership of National Health Commission (NHC) as essential partner for infectious diseases treatment and prevention in China and pave the way for inclusion of National Essential Drug List; • Led discussion for deployment of the Truvada for Pre-exposure Prophylaxis (PreP) with government key stakeholders;• Advocated and gained endorsement from NHC, China CDC for faster-tract Truvada PreP registration;• Established public-private-partnership inniatives with key provinces, for example: Shanghai, Zhejiang & Guangdong, in reviewing challenges and solutions for solution applications in these market, therefore invited for provincial RDL. Show less

Responsibilities: • Developed and oversaw the execution of Medical & External Affairs strategy and plan consistent with company’s core strategy with highest compliance and scientific standards; • Designed and nurtured the Medical & External Affairs team with 30+ head accounts to drive scientific and commercial success, covering from clinical trials for product registration, clinical research for publications, and large scale study proposals drafting, submission and execution, to shaping… Show more Responsibilities: • Developed and oversaw the execution of Medical & External Affairs strategy and plan consistent with company’s core strategy with highest compliance and scientific standards; • Designed and nurtured the Medical & External Affairs team with 30+ head accounts to drive scientific and commercial success, covering from clinical trials for product registration, clinical research for publications, and large scale study proposals drafting, submission and execution, to shaping public (with focus of infectious diseases) health policies, and leading market access to achieve pricing and reimbursement; • Established and enhanced institutional partnership with academic organizations, key opinion leaders, physicians, payers, policy makers and patients; • Worked closely with commercial, R&D, manufacturing, registration and other functions in an international matrix structure, to ensure a consistent and scientific approach for overall product lifecycle; • Represented the company to participate (planned and organized when appropriate) in intentional, regional and local conferences, symposia and meetings. Achievements: • Speeded up the National Drug Application (NDA) application process of HCV DAA (Danoprevir), which was submitted and accepted by China Food and Drug Administration (CFDA) in December 2016, including coordination to produce quality Mid-term ASC08 Clinical trial report within 20 days; • Managed Serious Adverse Event (SAE) of clinical study and ethnic review; • Led the proposal developing for application to National Thirteenth Grant for an Ascletis HIV drug and coordinate the process of application among partners;• Initiated the Zhejiang Province HCV Elimination Project (HERO) to demonstrate health economic benefits of treatment. Show less

Leading the Academy’s overall work in relation to scientific strategy and direction with a particular focus on research, innovation, evidenced based practice, quality improvement and professional leadership; provision of high level scientific advice and expertise to the Management Board, Council, Professional Advisory Groups and other scientific committee

I was team leader for China-EU Programme on HIV/STI service in Primary Health Service Centre in Urban area of China